Visual aspects of Behçet's disease

Current Treatment Options in Neurology

Volumn 8, Issue 1, 2006, Pages 81-88

  Kansu, Tulay ^a   Kadayifcilar, Sibel ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; AZATHIOPRINE; CHLORAMBUCIL; COLCHICINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; INFLIXIMAB; METHOTREXATE; PENTOXIFYLLINE; THALIDOMIDE; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

AUTOIMMUNITY; BEHCET DISEASE; BIOMICROSCOPY; CATARACT; DISEASE COURSE; DISEASE SEVERITY; DOSE RESPONSE; FLUORESCENCE ANGIOGRAPHY; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; IMMUNOPATHOGENESIS; INDOCYANINE GREEN ANGIOGRAPHY; IRIDOCYCLITIS; OPTIC NERVE DISEASE; OPTICAL COHERENCE TOMOGRAPHY; PAPILLEDEMA; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; RETINA NEOVASCULARIZATION; RETINA VASCULITIS; REVIEW; SECONDARY GLAUCOMA; UVEITIS;

EID: 29944432061     PISSN: 10928480     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11940-996-0026-6     Document Type: Review

References (49)

1. International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 1990, 335:1078-1080.
2. Verity DH, Wallace GR, Vaughan RW, Stanford MR: Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol 2003, 87:1175-1183.
3. Yoshida A, Kawashima H, Motoyama Y, et al.: Comparison of patients with Behçet's disease in the 1980s and 1990s. Ophthalmology 2004, 111:810-815.
4. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, et al.: Uveitis in Behçet's disease: an analysis of 880 patients. Am J Ophthalmol 2004, 138:373-380.
5. Kadayifcilar S, Eldem B, Tumer B: Uveitis in childhood. J Pediatr Ophthalmol Strabismus 2003, 40:335-340.
6. Tugal-Tutkun I, Urgancioglu M: Childhood-onset uveitis in Behçet's disease: a descriptive study of 36 cases. Am J Ophthalmol 2003, 136:1114-1119.
7. Rohatgi J, Singal A: Ocular manifestations of Behçet's disease in Indian patients. Indian J Ophthalmol 2003, 51:309-313.
8. Zamir E, Bodaghi B, Tugal-Tutkun I, et al.: Conjunctival ulcers in Behçet's disease. Ophthalmology 2003, 110:1137-1141.
9. Kadayifcilar S, Gedik S, Eldem B, Irkec M: Cataract surgery in patients with Behçet's disease. J Cataract Refract Surg 2002, 28:316-320.
10. Berker N, Soykan E, Elgin U, Ozkan SS: Phacoemulsification cataract extraction and intraocular lens implantation in patients with Behçet's disease. Ophthalmic Surg Lasers Imaging 2004, 35:215-218.
11. Elgin U, Berker N, Batman A: Incidence of secondary glaucoma in Behçet's disease. J Glaucoma 2004, 13:441-444.
12. Yalvac IS, Sungur G, Turhan E, et al.: Trabeculectomy with mitomycin C in uveitic glaucoma associated with Behcet's disease. J Glaucoma 2004, 13:450-453.
13. Ozdal PC, Ortac S, Taskintuna I, Firat E: Posterior segment involvement in ocular Behçet's disease. Eur J Ophthalmol 2002, 12:424-431.
14. Inomata H, Yoshikowa H, Rao NA: Phacoanaphylaxis in Behçet's disease. A clinical and immunohistochemical study. Ophthalmology 2003, 110:1942-1945.
15. Rabiah PK, Vitale AT: Noninfectious uveitis and pregancy. Am J Ophthalmol 2003, 136:91-98.
16. Yalcindag N, Yilmaz N, Tekeli O, Ozdemir O: Acute optic neuropathy in Behcet's disease. Eur J Ophthalmol 2004, 14:578-580.
17. Lamari H, Baha AT, Benhaddou M, et al.: Involvement of the optic nerve in the course of Behçet's disease (presentation of 148 cases). Bull Soc Belge Ophthalmol 2003, 289:9-14.
18. Siva A, Altintas A, Saip S: Behçet's syndrome and the nervous system. Curr Opin Neurol 2004, 17:347-357.
19. Aydin MD, Aydin N: A neuro-Behçet's lesion in oculomotor nerve nucleus. Acta Neurol Scand 2003, 108:139-141.
20. Gul A, Hajeer AH, Worthington J, et al.: Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23. Arthritis Rheum 2001, 44:2693-2696.
21. Yazici H: Behçet's syndrome: an update. Curr Rheumatol Rep 2003, 5:195-199.
22. Beck S: The Human Genome Project: what we have learnt about the MHC region on chromosome 6 and its potential to Behçet's disease. Adv Exp Med Biol 2003, 528:207-211.
23. Karasneh JA, Hajeer AH, Silman A, et al.: Polymorphisms in the endothelial nitric oxide synthase gene are associated with Behçet's disease. Rheumatology 2005, 44:614-617.
24. Duymaz-Tozkir J, Gul A, Uyar FA, et al.: Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease. Clin Exp Rheumatol 2003, 21(4 Suppl 30):S15-S18.
25. Duymaz-Tozkir J, Yilmaz V, Uyar FA, et al.: Polymorphisms of the IL-8 and CXCR2 genes are not associated with Behçet's disease. J Rheumatol 2005, 32:93-97.
26. Leiba M, Seligsohn U, Sidi Y, et al.: Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 2004, 63:1445-1449.
27. Gurgey A, Balta G, Boyvat A: Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behçet's disease. Blood Coagul Fibrinolysis 2003, 14:121-124.
28. Batioglu F, Atmaca LS, Karabulut HG, Beyza Sayin D: Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease. Acta Ophthalmol Scand 2003, 81:283-285.
29. Silingardi M, Salvarani C, Boiardi L, et al.: Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum 2004, 51:177-183.
30. Feki M, Houman H, Ghannouchi M, et al.: Hyperhomocysteinaemia is associated with uveitis but not with deep venous thrombosis in Behçet's disease. Clin Chem Lab Med 2004, 42:1417-1423.
31. Probst K, Fijnheer R, Rothova A: Endothelial cell activation and hypercoagulability in ocular Behçet's disease. Am J Ophthalmol 2004, 137:850-857.
32. Ozturk MA, Calguneri M, Kiraz S, et al.: Angiotensin-converting enzyme gene polymorphism in Behçet's disease. Clin Rheumatol 2004, 23:142-146.
33. Bardak Y, Aridogan BC: The demonstration of serum interleukin 6-8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement. Ocul Immunol Inflamm 2004, 12:53-58.
34. Kaburaki T, Fujino Y, Kawashima H, et al.: Plasma and whole-blood chemokine levels in patients with Behçet's disease. Graefes Arch Clin Exp Ophthalmol 2003, 241:353-358.
35. Yu HG, Lee DS, Seo JM, et al.: The number of CD8+ T cells and NKT cells increases in the aqueous humor of patients with Behçet's uveitis. Clin Exp Immunol 2004, 137:437-443.
36. Atmaca LS, Sonmez PA: Fluorescein and indocyanine green angiography findings in Behçet's disease. Br J Ophthalmol 2003, 87:1466-1468.
37. Gedik S, Akova Y, Yilmaz G, Bozbeyoglu S: Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behçet's disease. Ocul Immunol Inflamm 2005, 13:51-58.
38. Klaeger AJ, Tran VT, Hiroz CA, et al.: Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in Behçet's uveitis. Int Ophthalmol 2004, 25:47-63.
39. Karacorlu M, Mudun B, Ozdemir H, et al.: Intravitreal triamcinolone acetonide for the treatment of cystoid macular edema secondary to Behçet's disease. Am J Ophthalmol 2004, 138:289-291.
40. Tekeli O, Ozdemir O: Heidelberg retina tomograph in ocular Behçet's disease. Eye 2004, 18:143-146.
41. Toker E, Kazokoglu H, Acar N: High dose intravitreal steroid therapy for severe posterior segment uveitis in Behçet's disease. Br J Ophthalmol 2002, 86:321-323.
42. Kramer M, Ehrlich R, Snir M, et al.: Intravitreal injection of triamcinolone acetonide for severe vitritis in patients with incomplete Behçet's disease. Am J Ophthalmol 2004, 138:666-667.
43. Ozdal PC, Ortac S, Taskintuna I, Firat E: Long term therapy with low dose cyclosporin A in ocular Behçet's disease. Doc Ophthalmol 2002, 105:301-312.
44. Kotter I, Zierhut M, Eckstein AK, et al.: Human recombinant interferon-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 2003, 87:423-431.
45. Deuter CM, Kotter I, Gunaydin I, et al.: Ocular involvement in Behçet's disease: first 5-year-results for visual development after treatment with interferon alpha-2a. Ophthalmologe 2004, 101:129-134.
46. Kotter I, Vonthein R, Zierhut M, et al.: Differential efficacy of human recombinant interferon-alpha2a on ocular and extraocular manifestations of Behçet's disease. Semin Arthritis Rheum 2004, 33:311-319.
47. Wechsler B, Sable-Fourtassou R, Bodaghi B, et al.: Infliximab in refractory uveitis due to Behçet's disease. Clin Exp Rheumatol 2004, 22:14-16.
48. Giansanti F, Barbera ML, Virgili G, et al.: Infliximab for the treatment of posterior uveitis with retinal neovascularization in Behçet disease. Eur J Ophthalmol 2004, 14:445-458.
49. Ohno S, Nakamura S, Hori S, et al.: Efficacy, safety and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol 2004, 31:1362-1368.